First Light Asset Management »

Rhythm Pharmaceuticals shares owned by First Light Asset Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $32M 296k 107.04
2025-09-30 $18M 181k 100.99

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Neogenomics Common Stocks (NEO)
Si-bone Common Stocks (SIBN)
Palvella Therapeutics Common Stocks (PVLA)
Centessa Pharmaceuticals Common Stocks (CNTA)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Atricure Common Stocks (ATRC)
Vera Therapeutics Common Stocks (VERA)
Disc Medicine Common Stocks (IRON)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Edgewise Therapeutics Common Stocks (EWTX)
Madrigal Pharmaceuticals Common Stocks (MDGL)
Twist Bioscience Corporation Common Stocks (TWST)
Simulations Plus Common Stocks (SLP)
Rhythm Pharmaceuticals Common Stocks (RYTM)

View all positions for First Light Asset Management

Top funds holding Rhythm Pharmaceuticals

Perceptive Advisors
BlackRock
Vanguard Group
RA Capital Management
Baker Bros. Advisors
PRIMECAP Management Company
NEA Management Company
State Street Corporation
FMR
Goldman Sachs Group
Federated Investors
Driehaus Capital Management
Geode Capital Management
Westfield Capital Management Company
Jpmorgan Chase & Co

View all funds holding Rhythm Pharmaceuticals